↓ Skip to main content

Efficacy and safety of novel carbapenem–β-lactamase inhibitor combinations: Results from phase II and III trials

Overview of attention for article published in Frontiers in Cellular and Infection Microbiology, September 2022
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
13 Mendeley